Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
about
Multi-organ Mapping of Cancer RiskHistone H3 mutations--a special role for H3.3 in tumorigenesis?Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic TargetsA Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG).Role of KCNB1 in the prognosis of gliomas and autophagy modulation.Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.Pediatric high-grade glioma: biologically and clinically in need of new thinkingDetecting the H3F3A mutant allele found in high-grade pediatric glioma by real-time PCR.Quantitative interactome analysis reveals a chemoresistant edgotype.Pediatric gliomas as neurodevelopmental disordersLong non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.Biodegradable micelles enhance the antiglioma activity of curcumin in vitro and in vivo.Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesIdentification of complex genomic rearrangements in cancers using CouGaRCharacterizing and targeting PDGFRA alterations in pediatric high-grade glioma.Genomic Insights into Diffuse Intrinsic Pontine Glioma.Recent advances in understanding contextual TGFβ signalingIn vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopy.MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.Investigational new drugs for brain cancer.Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222.New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.Insights into molecular therapy of glioma: current challenges and next generation blueprintBrain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRIHigh-grade glioma in very young children: a rare and particular patient population.The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells.Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.Protein Phosphatase Magnesium-Dependent 1δ (PPM1D) Expression as a Prognostic Marker in Adult Supratentorial Diffuse Astrocytic and Oligodenroglial Tumors.Natural Agents-Mediated Targeting of Histone Deacetylases.CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.Signaling pathways and mesenchymal transition in pediatric high-grade glioma.Freiburg neuropathology case conference : Brainstem tumor in a child.Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers.Replication-Coupled Nucleosome Assembly in the Passage of Epigenetic Information and Cell Identity.
P2860
Q26701396-EB09043B-34FA-4E7D-B719-02D2A85AD498Q26865965-968D611B-2692-48B5-8E79-183E0FB9D37FQ30251385-EC935B30-1326-40E8-BDC6-7A6243BF38C5Q33615351-8590B018-2639-4066-8F95-8E14D7851935Q33671288-36D828E4-03B0-47A8-B438-96029940F531Q33771688-05FF85C9-DB74-4185-9AC3-81B25F4ACDA4Q33777868-5A5DDD0D-3297-4C44-9ED2-D70F315ECA3DQ35777520-D12FFF23-88A7-4249-9CE8-76B2975D4C14Q35941833-B57552F7-6E0F-4E24-9F06-06CB9743EC67Q36803476-B80AAE3A-A1A0-4FAE-8D14-ADE3CF9C706FQ36976091-49DC9FAA-5231-44E2-84C8-074A8BB015C2Q37003820-E7D265FC-A2B2-465F-8540-7EE0617FA710Q37213305-2713CC0A-AF7E-4F4C-8F7A-A7DB281A8BAAQ37548472-B8BBE16B-8635-45F4-B006-980E8F94D838Q37662300-629DC19F-E57E-42AA-9DEE-595A45D7BB6DQ37723508-A5EAE2FD-8BBA-48F5-A5D7-F71D83474EA4Q38666840-ACCDC0F3-7649-4FCB-A981-764A31A7E07EQ38680891-0A12291E-6A87-466A-B670-C1E174658162Q38713523-10340528-DD27-40D1-BAD3-59FAECF61049Q38720885-FFF549F7-8F27-4083-9BF9-90BECCF6B8C4Q38784189-C6F966DE-9998-40B1-8833-8DCD43006A6DQ38832510-8C573F0A-D084-44B7-BA1B-D8A24B3BA101Q38835306-A1C0418D-DF8E-42ED-8D8E-9849C9494329Q39167472-CD6FDE1A-91FB-496A-A542-52F8E0F887A2Q39187306-8CD12170-70BF-4BFF-94BC-E947A033AF57Q39218100-DC94F4F6-5231-43DA-8DD6-F34D7C9EC615Q39531754-7FE45BDB-5920-4B87-966F-B500E9012325Q41288834-91645B01-449B-4C44-B954-DF7F18D544D3Q42362800-A7BA735E-538A-44AC-9144-CB09E46CBD8AQ42366633-D714EFA5-2C3E-42A7-B47E-A27551997281Q42375231-D9B4B1A7-9BC2-4277-A860-61006176F829Q46512368-E6F33C0D-6602-4686-ACFB-A72C94B8A48DQ47631527-3441BE2B-8417-44B0-BDEA-99826FCB4126Q47740361-41FCA096-40C1-4C26-8A71-B114F46AB065Q47979443-09705AD4-1797-43DD-87F3-8324C6712C32Q48258004-57159A7D-EC9E-4D1B-A5F6-9EECA7850AA8Q48524897-92E30D76-83C6-48F8-9E64-ABEEC24106D7Q50089322-EE3C51A5-93D3-481D-A2C3-FE1BFA934AB4Q50733824-7A6215C9-65C2-4C61-B200-CFAE7174D849Q52733069-4B73A6EC-6B66-4576-84AC-E1BC2C8BCD50
P2860
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
@ast
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
@en
type
label
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
@ast
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
@en
prefLabel
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
@ast
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
@en
P2860
P356
P1476
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
@en
P2093
Suzanne J Baker
P2860
P2888
P356
10.1038/NRC3811
P407
P50
P577
2014-10-01T00:00:00Z